MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma. Kwon M, Lim D, Park J, Gil W, et al. Anticancer Res 2024;44:4283-4299.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwon M, Lim D, Park J, Gil W, et al. MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma. Anticancer Res 2024;44:4283-4299.
PMID: 39348965